Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk R&D spend jumps 35% thanks to soaring sales as oral obesity plans advance
Fierce Biotech
Wed, 01/31/24 - 11:55 am
Novo Nordisk
R&D
obesity
amycretin
As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke
Fierce Pharma
Tue, 01/30/24 - 09:26 pm
AstraZeneca
Novo Nordisk
legal
Inflation Reduction Act
HHS
drug pricing
Will Novo Nordisk Be a $1 Trillion Company by 2030?
Motley Fool
Tue, 01/30/24 - 10:40 am
Novo Nordisk
obesity
diabetes
kidney disease
2 Rising Biotechs That Could Become the Next Novo Nordisk
Motley Fool
Mon, 01/29/24 - 11:04 am
Novo Nordisk
Madrigal Pharmaceuticals
Viking Therapeutics
NASH
Novo Nordisk Puts Pharma Peers in the Shade as Key Earnings Reports Awaited
Yahoo/Bloomberg
Sun, 01/28/24 - 06:27 pm
Novo Nordisk
earnings
No decision yet on Wegovy heart benefits from EU drug regulator
Reuters
Fri, 01/26/24 - 11:16 am
Novo Nordisk
Wegovy
heart attacks
stroke
Europe
Many patients keep weight off after stopping anti-obesity meds: study
Axios
Wed, 01/24/24 - 10:44 am
obesity
Novo Nordisk
Ozempic
Wegovy
Saxenda
Victoza
Novo Nordisk Inks Potential $255M Deal with EraCal, Targets Another Obesity Asset
BioSpace
Tue, 01/23/24 - 06:02 pm
Novo Nordisk
obesity
EraCal Therapeutics
New Wegovy TV Commercial Launched After Pause to Deal with High Demand
Xtalks
Sun, 01/21/24 - 05:20 pm
Novo Nordisk
Wegovy
television ads
United States of Ozempic: Where anti-obesity drugs are taking off
Axios
Fri, 01/19/24 - 09:31 am
Ozempic
Zepbound
Wegovy
Novo Nordisk
Eli Lilly
obesity
United States
Researchers probe new uses of popular weight loss, diabetes drugs
Beckers Hospital Review
Tue, 01/16/24 - 09:08 am
GLP-1 agonist
Ozempic
Mounjaro
Wegovy
Novo Nordisk
Eli Lilly
Novo Nordisk resumes shipments of Wegovy 1.7 mg dose in US
Reuters
Mon, 01/15/24 - 09:36 am
Novo Nordisk
Wegovy
Roche is ‘on par’ with Novo, Lilly in GLP-1 race after $2.7B Carmot deal
Medical Devices and Diagnostics Industry
Fri, 01/12/24 - 11:33 am
Roche
Carmot
GLP-1 agonist. obesity
Novo Nordisk
Eli Lilly
FDA says no evidence yet linking weight loss drugs to suicidal thoughts
Reuters
Thu, 01/11/24 - 11:35 am
Novo Nordisk
Eli Lilly
weight loss
GLP-1 agonist
FDA
JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage
Medical Marketing and Media
Thu, 01/11/24 - 11:18 am
JPMHC 2024
obesity
diabetes
diabesity
Novo Nordisk
Eli Lilly
JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says
Fierce Pharma
Wed, 01/10/24 - 06:27 pm
Novo Nordisk
obesity
Wegovy
Lars Fruergaard Jorgensen
JPMHC 2024
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
Novo CEO expects patients to stay on Wegovy longer than older weight loss drugs
Reuters
Tue, 01/9/24 - 09:59 pm
Novo Nordisk
Pharma CEOs
Wegovy
patients
Lars Fruergaard Jorgensen
JPMHC 2024
Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds
Reuters
Fri, 01/5/24 - 09:55 am
Novo Nordisk
Wegovy
Ozempic
side effects
Novo Nordisk, Eli Lilly's weight-loss drugs under FDA scrutiny for suicidal thoughts, hair loss
Fierce Pharma
Thu, 01/4/24 - 11:53 am
Novo Nordisk
Eli Lilly
weightloss
side effects
Ozempic
Wegovy
Zepbound
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »